Mars Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 14.25 Cr
as on 16-11-2024
- Paid Up Capital ₹ 13.88 Cr
as on 16-11-2024
- Company Age 31 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 15.74 Cr
as on 16-11-2024
- Satisfied Charges ₹ 28.31 Cr
as on 16-11-2024
- Revenue 4.43%
(FY 2023)
- Profit 8.61%
(FY 2023)
- Ebitda 3.60%
(FY 2023)
- Net Worth 15.95%
(FY 2023)
- Total Assets 19.44%
(FY 2023)
About Mars Therapeutics
The Corporate was formerly known as Mars Therapeutics And Chemicals Private Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 14.25 Cr and a paid-up capital of Rs 13.88 Cr.
The company currently has active open charges totaling ₹15.74 Cr. The company has closed loans amounting to ₹28.31 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Mars Therapeutics Private Limited India are Gade Swapna as COMPANY SECRETARY and Maddula Rao as Cfo. Apparao Pullela and Rajasekhar Pullela serve as directors at the Company.
- CIN/LLPIN
U24239TG1993PTC015547
- Company No.
015547
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Mar 1993
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Mars Therapeutics Private Limited offer?
Mars Therapeutics Private Limited offers a wide range of products and services, including Legal Drafting Services, Contract Management Service, Pharmaceutical Services, Formulation Development Service.
Who are the key members and board of directors at Mars Therapeutics?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajasekhar Pullela  | Managing Director | 15-Oct-2012 | Current |
| Gade Swapna | Company Secretary | 31-Jul-2021 | Current |
| Maddula Rao | CFO | 29-Nov-2019 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Apparao Pullela | Director | 30-Sep-2008 | Current |
Financial Performance of Mars Therapeutics.
Mars Therapeutics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.43% increase. The company also saw a slight improvement in profitability, with a 8.61% increase in profit. The company's net worth Soared by an impressive increase of 15.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mars Therapeutics?
In 2023, Mars Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mars Pharma Private LimitedActive 11 years 5 monthsApparao Pullela and Rajasekhar Pullela are mutual person
Aarvi Pharmatech LlpActive 2 years 4 monthsApparao Pullela and Rajasekhar Pullela are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Nov 2022 | ₹5.40 Cr | Open |
Others Creation Date: 13 Jun 2022 | ₹1.00 Cr | Open |
Others Creation Date: 23 Mar 2022 | ₹1.00 Cr | Open |
How Many Employees Work at Mars Therapeutics?
Mars Therapeutics has a workforce of 152 employees as of Jul 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mars Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mars Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
